Enter your username/e-mail and your new password will be send to you.
| Description | The Life Sciences Division of the CEA, the Institut Pasteur, the “Institut National de la Santé et de la Recherche Médicale” (INSERM), the “Agence Nationale de Recherche sur le SIDA et les Hépatites Virales” (ANRS), Université Paris Sud 11 (UPS-11) and Bertin Pharma decided to join forces to create a research center for “Infectious Disease Models and Innovative Therapies” (IDMIT) at the CEA site in Fontenay-aux-Roses. This center is dedicated to preclinical research programs on human vaccines and antimicrobial treatments. It is equipped with state-of-the-art facilities for animal studies and in vitro assays. The infrastructure also develops advanced technologies for monitoring infections and host responses, including in vivo imaging in BSL3 containment (near infra-red fluorescence, confocal endo-microscopy, two-photon microscopy, PET-CT) and complex cell phenotyping (CyTof). The center is targeted at the academic and industrial scientific communities. 50% of the capacity of the centre has been operational and accessible as of 2012, while the fully equipped infrastructure will be operational in 2017. |
| URL | http://www.idmitcenter.fr/ |
| Status | Operational since 2012 Under construction (1901 - 2017) |
| Scientific Domains | Biological and Medical Sciences |
| RI Categorization | Safety Handling facilities |
| Location | 18 Route du Panorama, Fontenay-aux-Roses, 92 265, France |
| MERIL URL | http://portal.meril.eu/meril/view/facilitys/15730 |
